KS
Kevin M Sun
Chief Financial Officer

Kevin M Sun insider trades: DermTech (DMTK) stock sales

Chief Financial Officer, DermTech Last trade Dec 11, 2023 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2021
1
Company
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 11, 2023DMTK↓ Sell$8K
Sep 11, 2023DMTK↓ Sell$19K
Jun 12, 2023DMTK↓ Sell$1K
Jun 8, 2023DMTK↓ Sell$20K
Mar 13, 2023DMTK↓ Sell$2K
Mar 8, 2023DMTK↓ Sell$47K
Sep 6, 2022DMTK↓ Sell$967
Mar 11, 2022DMTK↓ Sell$6K
Mar 8, 2022DMTK↓ Sell$46K
Sep 13, 2021DMTK↓ Sell$23K
Sep 8, 2021DMTK↓ Sell$155K
Jun 11, 2021DMTK↓ Sell$79K
Jun 8, 2021DMTK↓ Sell$125K
Mar 8, 2021DMTK↓ Sell$144K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Kevin M Sun's insider trades

Kevin M Sun is Chief Financial Officer at DermTech (DMTK). Since Mar 8, 2021, Kevin has reported no open-market purchases and 14 sales worth $675K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (6 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DMTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.